HCMT
DTIL icon

Highland Capital Management (Texas)’s Precision BioSciences DTIL Stock Holding History

Highland Capital Management (Texas)’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$861K Hold
2,167
– – 0.05% 218
2019
Q1 		$1.17M Buy
+2,167
New +$1.15M 0.07% 193

Other funds holding DTIL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Highland Capital Management (Texas)'s DTIL Position: Q2 2019 in Review

Highland Capital Management (Texas) held its Precision BioSciences (DTIL) position steady in Q2 2019 at 2,167 shares worth $861K. The position accounts for 0.05% of the portfolio, ranked #218.

Highland Capital Management (Texas) first reported a position in DTIL in Q1 2019 and has held it in 2 quarters since. The position peaked at $1.17M in Q1 2019. 63 funds tracked by Wall St. Rank hold DTIL as of Q2 2019.

  • Highland Capital Management (Texas) held 2,167 shares of Precision BioSciences worth $861K as of Q2 2019.
  • Highland Capital Management (Texas) left its Precision BioSciences share count unchanged in Q2 2019.
  • Precision BioSciences made up 0.05% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #218 holding.
  • Highland Capital Management (Texas) first reported a position in Precision BioSciences in Q1 2019 and has held it in 2 quarters since.
  • Highland Capital Management (Texas)'s Precision BioSciences position peaked at $1.17M in Q1 2019.
  • 63 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.